20
Sanofi Chimie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Tiapride hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2002-113 - Rev 03
This Chemical Type CEP, issued on April 03, 2014, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1575 associated with this CEP further emphasizes